GUARDION HEALTH SCIENCES INC (GHSI) Stock Price, Forecast & Analysis
USA - NASDAQ:GHSI - US40145Q5009 - Common Stock
GHSI Key Statistics, Chart & Performance
The current stock price of GHSI is 3.25 USD. In the past month the price decreased by -67.2%. In the past year, price decreased by -53.64%.
GHSI Latest News, Press Relases and Analysis
GHSI Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| EL | ESTEE LAUDER COMPANIES-CL A | 53.35 | 32.30B | ||
| KVUE | KENVUE INC | 15.67 | 32.18B | ||
| ELF | ELF BEAUTY INC | 25.84 | 4.53B | ||
| BRBR | BELLRING BRANDS INC | 13.03 | 3.56B | ||
| COTY | COTY INC-CL A | 18.68 | 3.10B | ||
| IPAR | INTERPARFUMS INC | 16.61 | 2.80B | ||
| EPC | EDGEWELL PERSONAL CARE CO | 7.3 | 874.84M | ||
| OLPX | OLAPLEX HOLDINGS INC | 14.25 | 760.47M | ||
| NUS | NU SKIN ENTERPRISES INC - A | 7.15 | 488.56M | ||
| USNA | USANA HEALTH SCIENCES INC | 9.79 | 350.42M | ||
| NATR | NATURES SUNSHINE PRODS INC | 21.04 | 348.92M | ||
| HNST | HONEST CO INC/THE | 43.67 | 291.53M |
Related stock screener links
About GHSI
Company Profile
Guardion Health Sciences, Inc. engages in the business of developing and distributing clinically supported nutrition, medical foods, and dietary supplements. The company is headquartered in Houston, Texas and currently employs 9 full-time employees. The company went IPO on 2019-04-05. The firm offers a portfolio of science-based, clinically supported products designed to support the health needs of consumers, healthcare professionals and providers and their patients. The firm sells two ocular products: GlaucoCetin and Lumega-Z. GlaucoCetin is a dietary supplement in a capsule form designed specifically to provide nutrients to support mitochondrial function with additional antioxidants to help reduce oxidative stress and increase blood flow throughout the body for enhanced eye support and ocular health. Lumega-Z, its medical food product, has a formula designed to replenish and restore the macular protective pigment, simultaneously delivering critical and essential nutrients to the eye. As a medical food, Lumega-Z must be administered under the supervision of a physician or professional healthcare provider. The company sells GlaucoCetin and Lumega-Z on its Website, guardionhealth.com.
Company Info
GUARDION HEALTH SCIENCES INC
2925 Richmond Avenue, Suite 1200
Houston TEXAS 92128 US
CEO: Bret Scholtes
Employees: 9
Phone: 18008735141
GUARDION HEALTH SCIENCES INC / GHSI FAQ
What does GHSI do?
Guardion Health Sciences, Inc. engages in the business of developing and distributing clinically supported nutrition, medical foods, and dietary supplements. The company is headquartered in Houston, Texas and currently employs 9 full-time employees. The company went IPO on 2019-04-05. The firm offers a portfolio of science-based, clinically supported products designed to support the health needs of consumers, healthcare professionals and providers and their patients. The firm sells two ocular products: GlaucoCetin and Lumega-Z. GlaucoCetin is a dietary supplement in a capsule form designed specifically to provide nutrients to support mitochondrial function with additional antioxidants to help reduce oxidative stress and increase blood flow throughout the body for enhanced eye support and ocular health. Lumega-Z, its medical food product, has a formula designed to replenish and restore the macular protective pigment, simultaneously delivering critical and essential nutrients to the eye. As a medical food, Lumega-Z must be administered under the supervision of a physician or professional healthcare provider. The company sells GlaucoCetin and Lumega-Z on its Website, guardionhealth.com.
What is the current price of GHSI stock?
The current stock price of GHSI is 3.25 USD. The price decreased by -0.31% in the last trading session.
What is the dividend status of GUARDION HEALTH SCIENCES INC?
GUARDION HEALTH SCIENCES INC (GHSI) has a dividend yield of 153.85%. The yearly dividend amount is currently 0.
How is the ChartMill rating for GUARDION HEALTH SCIENCES INC?
GHSI has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
Which stock exchange lists GHSI stock?
GHSI stock is listed on the Nasdaq exchange.
Can you provide the PE ratio for GHSI stock?
The PE ratio for GUARDION HEALTH SCIENCES INC (GHSI) is 7.56. This is based on the reported non-GAAP earnings per share of 0.43 and the current share price of 3.25 USD.
Would investing in GUARDION HEALTH SCIENCES INC be a good decision?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on GHSI.
GHSI Technical Analysis
GHSI Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to GHSI. GHSI has a great financial health rating, but its profitability evaluates not so good.
GHSI Financial Highlights
Over the last trailing twelve months GHSI reported a non-GAAP Earnings per Share(EPS) of 0.43. The EPS increased by 154.16% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 99.1% | ||
| ROA | 41.65% | ||
| ROE | 46.34% | ||
| Debt/Equity | 0 |
GHSI Forecast & Estimates
7 analysts have analysed GHSI and the average price target is 40.8 USD. This implies a price increase of 1155.38% is expected in the next year compared to the current price of 3.25.
For the next year, analysts expect an EPS growth of -669.3% and a revenue growth 9.56% for GHSI